— Know what they know.
Not Investment Advice

SRBT OTC

Shanrong Biotechnology Corp.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: -99.9% 1Y: -100.0% 3Y: -100.0% 5Y: -99.8%
$0.00
+0.00 (+0.00%)
 
OTC · Financial Services · Shell Companies · Tech Score Neutral · Power 45 · $100048 mcap · 589M float · 0.0010% daily turnover · Short 67% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.1M
52W Range0.000099999997-0.3439
Volume6,600
Avg Volume6,087
Beta0.10
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOColonel Timothy D. Ringgold
Employees3
SectorFinancial Services
IndustryShell Companies
IPO Date2018-02-09
370 Amapola Ave.
Torrance, CA 90501
US
310-359-6895
About Shanrong Biotechnology Corp.

Shanrong Biotechnology Corp. primarily functions as a provider of executive consulting and project management services. The company specializes in the modernization of armored vehicles, integrating advanced digital communications into their systems. Furthermore, it furnishes critical spare parts and specialized equipment to both military and law enforcement organizations. Beyond hardware provision, its service portfolio also encompasses on-site maintenance, along with comprehensive training programs for maintenance personnel, operators, and tactical operations. Shanrong's expertise additionally extends to program oversight, business expansion initiatives, and strategic analysis within the defense, homeland security, information technology, and telecommunications industries. The entity, formerly known as Defense Solutions Holding, Inc., officially adopted its current name, Shanrong Biotechnology Corp., in September 2017. It is headquartered in Beverly Hills, California.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms